全文获取类型
收费全文 | 1547篇 |
免费 | 1篇 |
专业分类
电工技术 | 24篇 |
综合类 | 1篇 |
化学工业 | 223篇 |
金属工艺 | 70篇 |
机械仪表 | 53篇 |
建筑科学 | 7篇 |
矿业工程 | 30篇 |
能源动力 | 16篇 |
水利工程 | 83篇 |
石油天然气 | 70篇 |
无线电 | 100篇 |
一般工业技术 | 273篇 |
冶金工业 | 505篇 |
原子能技术 | 55篇 |
自动化技术 | 38篇 |
出版年
2020年 | 15篇 |
2019年 | 21篇 |
2018年 | 50篇 |
2017年 | 28篇 |
2016年 | 44篇 |
2015年 | 24篇 |
2014年 | 22篇 |
2013年 | 42篇 |
2012年 | 37篇 |
2011年 | 39篇 |
2010年 | 22篇 |
2009年 | 30篇 |
2008年 | 41篇 |
2007年 | 30篇 |
2006年 | 20篇 |
2005年 | 28篇 |
2004年 | 19篇 |
2003年 | 18篇 |
2002年 | 15篇 |
2000年 | 21篇 |
1999年 | 27篇 |
1998年 | 130篇 |
1997年 | 78篇 |
1996年 | 61篇 |
1995年 | 31篇 |
1994年 | 27篇 |
1993年 | 31篇 |
1990年 | 14篇 |
1989年 | 25篇 |
1988年 | 22篇 |
1986年 | 16篇 |
1985年 | 14篇 |
1984年 | 13篇 |
1983年 | 17篇 |
1980年 | 29篇 |
1979年 | 19篇 |
1978年 | 19篇 |
1977年 | 29篇 |
1976年 | 47篇 |
1975年 | 17篇 |
1974年 | 22篇 |
1973年 | 43篇 |
1972年 | 24篇 |
1971年 | 23篇 |
1970年 | 22篇 |
1969年 | 19篇 |
1968年 | 18篇 |
1967年 | 15篇 |
1966年 | 13篇 |
1965年 | 13篇 |
排序方式: 共有1548条查询结果,搜索用时 15 毫秒
61.
Two cases of papillary thryoid carcinoma presenting as a cystic lateral neck mass are reported. This tumour characteristically presents in patients under 40-years-old and in the presence of an occult primary tumour may mimic a branchial cyst. In such cases simple aspiration of the cyst will produce a chocolate-brown serous fluid which excludes the diagnosis of a branchial cyst and is characteristic of papillary thyroid carcinoma. Cytological examination of the fluid has a high degree of sensitivity and specificity in the diagnosis of thyroid malignancy and should avoid delay in diagnosis and unnecessary surgical exploration prior to definitive treatment. 相似文献
62.
GB Scarfe B Wright E Clayton S Taylor ID Wilson JC Lindon JK Nicholson 《Canadian Metallurgical Quarterly》1998,28(4):373-388
63.
DA Renzoni DJ Pugh G Siligardi P Das CJ Morton C Rossi MD Waterfield ID Campbell JE Ladbury 《Canadian Metallurgical Quarterly》1996,35(49):15646-15653
The interaction of the Fyn SH3 domain with the p85 subunit of PI3-kinase is investigated using structural detail and thermodynamic data. The solution structure complex of the SH3 domain with a proline-rich peptide mimic of the binding site on the p85 subunit is described. This indicates that the peptide binds as a poly(L-proline) type II helix. Circular dichroism spectroscopic studies reveal that in the unbound state the peptide exhibits no structure. Thermodynamic data for the binding of this peptide to the SH3 domain suggest that the weak binding (approximately 31 microM) of this interaction is, in part, due to the entropically unfavorable effect of helix formation (delta S0 = -78 J.mol-1.K-1). Binding of the SH3 domain to the intact p85 subunit (minus its own SH3 domain) is tighter, and the entropic and enthalpic contributions are very different from those given by the peptide interaction (delta S0 = +252 J.mol-1.K-1; delta H0 = +44 kJ.mol-1). From these dramatically different thermodynamic measurements we are able to conclude that the interaction of the proline-rich peptide does not effectively mimic the interaction of the intact p85 subunit with the SH3 domain and suggest that other interactions could be important. 相似文献
64.
H Kovacs ID Campbell P Strong S Johnson FJ Ward KB Reid P Eggleton 《Canadian Metallurgical Quarterly》1998,37(51):17865-17874
Calreticulin (CRT) is located predominantly in the endoplasmic reticulum (ER) of cells, where it functions as a quality control controller of protein folding. However, CRT is also a prevalent autoantigen in patients with systemic lupus erythematosus (SLE), where its release from the cell may arise as a results of dysfunctional apoptosis and inefficient removal of ER vesicles, which are an abundant source of CRT and other autoantigens. Indicative of this is the presence of autoantibodies against CRT in the sera of 40-60% of all SLE patients. Once released into the circulation, CRT might bind directly to C1q and we have suggested that this association may result in a defect in C1q-mediated clearance of antigen-antibody complexes. It has been previously shown that CRT under physiological salt conditions binds to the globular head of C1q. It is known that the globular head region of C1q binds to the CH2 domain in the Fc portion of immunoglobulin gamma (IgG). The N-terminal half of CRT contains a number of short regions of 7-10 amino acids that show sequence similarity to the putative C1q binding region in the CH2 domain of IgG. By use of a series of 92 overlapping CRT synthetic peptides, a number of C1q binding sites on the CRT molecule have been identified, including several containing a CH2-like motif similar to the ExKxKx C1q binding motif found in the CH2 domain of IgG. A number of these peptides were shown to inhibit binding of C1q to IgG and reduce binding of native CRT to C1q. Moreover, several of the peptides were capable of inhibiting the classical pathway of complement activation. These studies have identified specific binding sites on the CRT molecule for C1q and lend support to the hypothesis that interaction of CRT with C1q may interfere with the ability of C1q to associate with immune complexes in autoimmune-related disorders. 相似文献
65.
Adverse reactions to D-penicillamine after gold toxicity 总被引:1,自引:0,他引:1
The incidence of adverse reactions to D-penicillamine in 155 patients with rheumatoid arthritis was analysed and compared with their history of adverse reactions to gold. Out of 125 patients who took only D-penicillamine, 45 developed side effects from the drug, whereas of 27 patients with a history of gold toxicity, 18 also reacted adversely to D-penicillamine. All patients who took D-penicillamine within six months after an adverse reaction to gold developed side effects from D-penicillamine. Fourteen patients developed similar adverse reactions to D-penicillamine and gold, and the interval between treatments in this group was significantly shorter (p less than 0.01) than in those who developed either differing adverse reactions to both drugs or no reaction to D-penicillamine after treatment with gold. An interval exceeding six months between treatment with gold and treatment with D-penicillamine in patients who have developed adverse reactions to gold apparently reduces the risk of adverse reactions to D-penicillamine. 相似文献
66.
V. M. Mikhailov 《Atomic Energy》1975,39(3):861-862
67.
68.
69.
70.